• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物洗脱支架和支架在腘下动脉中的现状与未来前景

Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries.

作者信息

Lim Elizabeth, Varcoe Ramon L

机构信息

The Prince of Wales Hospital, Sydney, NSW 2031, Australia.

The Prince of Wales Hospital, University of New South Wales, Sydney, NSW 2031, Australia.

出版信息

J Clin Med. 2024 Mar 19;13(6):1757. doi: 10.3390/jcm13061757.

DOI:10.3390/jcm13061757
PMID:38541981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10970957/
Abstract

Chronic limb-threatening ischaemia can be a debilitating disease and may result in limb amputation if untreated. Atherosclerotic disease of the infra-popliteal arteries is particularly challenging to treat due to the small caliber of the vessels and the heavy burden of atherosclerotic plaque. Percutaneous transluminal angioplasty is the conventional first-line approach and is advantageous due to its minimal invasiveness, repeatability, and cost-effectiveness but is limited by high rates of elastic recoil, dissection, and short- to mid-term re-stenosis. This review analyses the growing body of published and presented clinical data from multiple randomised controlled trials that have investigated the role of coronary drug-eluting stents in the treatment of infrapopliteal disease. Coronary drug-eluting stents demonstrate superior primary patency compared with angioplasty and/or bare metal stenting alone but are limited to application in short-segment disease and have not been widely adopted due to the nature of the permanent implant. Newer devices like drug-eluting resorbable scaffolds are promising as they allow the restoration of vessel wall vasomotion without a residual foreign body and can be used to treat longer, complex lesions.

摘要

慢性肢体威胁性缺血是一种使人衰弱的疾病,若不治疗可能导致肢体截肢。由于腘下动脉血管口径小且动脉粥样硬化斑块负担重,治疗腘下动脉粥样硬化疾病特别具有挑战性。经皮腔内血管成形术是传统的一线治疗方法,因其微创性、可重复性和成本效益而具有优势,但受弹性回缩、夹层形成以及短期至中期再狭窄发生率高的限制。本综述分析了来自多项随机对照试验的越来越多已发表和展示的临床数据,这些试验研究了冠状动脉药物洗脱支架在治疗腘下疾病中的作用。与单纯血管成形术和/或裸金属支架置入相比,冠状动脉药物洗脱支架显示出更好的初始通畅率,但仅限于应用于短节段疾病,并且由于永久性植入物的性质尚未得到广泛应用。像药物洗脱可吸收支架这样的新型装置很有前景,因为它们能够在没有残留异物的情况下恢复血管壁的血管运动,并且可用于治疗更长、更复杂的病变。

相似文献

1
Current Status of and Future Prospects for Drug-Eluting Stents and Scaffolds in Infrapopliteal Arteries.药物洗脱支架和支架在腘下动脉中的现状与未来前景
J Clin Med. 2024 Mar 19;13(6):1757. doi: 10.3390/jcm13061757.
2
Angioplasty versus stenting for infrapopliteal arterial lesions in chronic limb-threatening ischaemia.血管成形术与支架置入术治疗慢性肢体威胁性缺血的腘下动脉病变
Cochrane Database Syst Rev. 2018 Dec 8;12(12):CD009195. doi: 10.1002/14651858.CD009195.pub2.
3
Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.下肢外周动脉疾病的支架置入术:一项基于证据的分析。
Ont Health Technol Assess Ser. 2010;10(18):1-88. Epub 2010 Sep 1.
4
Bioresorbable Scaffolds for Below-the-Knee Arterial Disease: A Literature Review of New Developments.用于膝下动脉疾病的生物可吸收支架:新进展的文献综述
Rev Cardiovasc Med. 2024 Apr 3;25(4):133. doi: 10.31083/j.rcm2504133. eCollection 2024 Apr.
5
Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit.对于严重肢体缺血患者,在腘下血管成形术效果欠佳后,西罗莫司洗脱支架与裸支架的比较:具有持续1年的血管造影和临床益处。
J Endovasc Ther. 2007 Apr;14(2):241-50. doi: 10.1177/152660280701400217.
6
Balloon Angioplasty of Infrapopliteal Arteries: A Systematic Review and Proposed Algorithm for Optimal Endovascular Therapy.腘下动脉球囊血管成形术:系统评价及最佳血管内治疗方案建议算法
J Endovasc Ther. 2020 Aug;27(4):547-564. doi: 10.1177/1526602820931488. Epub 2020 Jun 17.
7
Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials.药物洗脱支架治疗下肢动脉血管再通:随机试验的更新荟萃分析。
JACC Cardiovasc Interv. 2013 Dec;6(12):1284-93. doi: 10.1016/j.jcin.2013.08.007.
8
BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial.腿部严重缺血的球囊扩张术与支架置入术对比研究-3(BASIL-3):一项随机对照试验的研究方案
Trials. 2017 May 19;18(1):224. doi: 10.1186/s13063-017-1968-6.
9
Vein bypass first vs. best endovascular treatment first revascularisation strategy for chronic limb-threatening ischaemia due to infra-popliteal disease: the BASIL-2 RCT.静脉旁路术优先与最佳血管内治疗优先血运重建策略治疗下肢严重缺血性疾病:BASIL-2 RCT。
Health Technol Assess. 2024 Oct;28(65):1-72. doi: 10.3310/YTFV4524.
10
Comparation of drug-eluting stents and control therapy for the treatment of infrapopliteal artery disease: a Bayesian analysis.药物洗脱支架与对照治疗在治疗下肢动脉疾病中的比较:贝叶斯分析。
Int J Surg. 2023 Dec 1;109(12):4286-4297. doi: 10.1097/JS9.0000000000000736.

引用本文的文献

1
The Evolution of Vascular Interventional Radiology and Endovascular Surgery: An Overview of Recent Advances.血管介入放射学与血管内手术的发展:近期进展概述
J Clin Med. 2025 Feb 1;14(3):939. doi: 10.3390/jcm14030939.

本文引用的文献

1
Drug-Eluting Stents Versus Conventional Endovascular Therapies in Symptomatic Infrapopliteal Peripheral Artery Disease: A Meta-analysis.药物洗脱支架与传统血管内治疗方法治疗有症状的腘下外周动脉疾病的Meta分析
J Soc Cardiovasc Angiogr Interv. 2022 Apr 11;1(2):100024. doi: 10.1016/j.jscai.2022.100024. eCollection 2022 Mar-Apr.
2
Intravascular Lithotripsy for Peripheral Artery Calcification: Mid-term Outcomes From the Randomized Disrupt PAD III Trial.外周动脉钙化的血管内碎石术:随机化Disrupt PAD III试验的中期结果
J Soc Cardiovasc Angiogr Interv. 2022 May 19;1(4):100341. doi: 10.1016/j.jscai.2022.100341. eCollection 2022 Jul-Aug.
3
Evaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial.腘下药物洗脱可吸收支架的评估:LIFE-BTK随机对照试验的设计方法
J Soc Cardiovasc Angiogr Interv. 2023 May 19;2(4):100964. doi: 10.1016/j.jscai.2023.100964. eCollection 2023 Jul-Aug.
4
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication.编辑推荐——欧洲血管外科学会(ESVS)2024年无症状下肢外周动脉疾病和间歇性跛行管理临床实践指南
Eur J Vasc Endovasc Surg. 2024 Jan;67(1):9-96. doi: 10.1016/j.ejvs.2023.08.067. Epub 2023 Nov 10.
5
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease.药物洗脱可吸收支架与血管成形术治疗下肢动脉疾病。
N Engl J Med. 2024 Jan 4;390(1):9-19. doi: 10.1056/NEJMoa2305637. Epub 2023 Oct 25.
6
Primary results of the SAVAL randomized trial of a paclitaxel-eluting nitinol stent versus percutaneous transluminal angioplasty in infrapopliteal arteries.在腘下动脉中,紫杉醇洗脱镍钛合金支架与经皮腔内血管成形术对比的SAVAL随机试验的主要结果。
Vasc Med. 2023 Dec;28(6):571-580. doi: 10.1177/1358863X231199489. Epub 2023 Oct 16.
7
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first-in-human study.用于治疗初次冠状动脉病变的新型可吸收镁支架(DREAMS 3):BIOMAG-I 首次人体研究的一年结果。
EuroIntervention. 2023 Aug 7;19(5):e414-e422. doi: 10.4244/EIJ-D-23-00326.
8
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial.对于需要进行 below-the-knee(小腿)、伴或不伴额外更近端 below-inguinal(腹股沟下)血运重建以恢复肢体灌注的慢性肢体威胁性缺血患者,静脉旁路优先与最佳血管内治疗优先再血管化策略的比较(BASIL-2):一项开放标签、随机、多中心、3 期试验。
Lancet. 2023 May 27;401(10390):1798-1809. doi: 10.1016/S0140-6736(23)00462-2. Epub 2023 Apr 25.
9
Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study.第三代药物洗脱可吸收冠状动脉镁支架系统治疗初发冠状动脉病变患者的安全性和性能:前瞻性、多中心BIOMAG-I人体首次研究的6个月结果
EClinicalMedicine. 2023 Apr 17;59:101940. doi: 10.1016/j.eclinm.2023.101940. eCollection 2023 May.
10
Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials.生物可吸收血管支架与传统药物洗脱支架随时间变化的比较:随机对照试验的荟萃分析。
Open Heart. 2022 Oct;9(2). doi: 10.1136/openhrt-2022-002107.